+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Veterinary Oncology Market Research Report by Therapy, by Cancer Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 5305503
  • Report
  • June 2021
  • Region: Global
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Veterinary Oncology Market Grew USD 96.23 Million by 2026, at a CAGR of 9.02%

FEATURED COMPANIES

  • AB Science SA
  • Bayer AG
  • Covetrus, Inc.
  • Morphogenesis, Inc.
  • PetCure Oncology
  • Regeneus Ltd.
  • MORE
The Global Veterinary Oncology Market size was estimated at USD 57.31 Million in 2020 and expected to reach USD 62.29 Million in 2021, at a Compound Annual Growth Rate (CAGR) 9.02% from 2020 to 2026 to reach USD 96.23 Million by 2026.



Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Veterinary Oncology to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Therapy, the Veterinary Oncology Market was examined across Chemotherapy, Immunotherapy, Radiology, and Surgery.
  • Based on Animal Type, the Veterinary Oncology Market was examined across Canine and Feline.
  • Based on Cancer Type, the Veterinary Oncology Market was examined across Lymphoma, Mammary and Squamous Cell Cancer, and Mast Cell Cancer.
  • Based on Geography, the Veterinary Oncology Market was examined across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Veterinary Oncology Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Veterinary Oncology Market, including AB Science SA, Accuray Incorporated, AdvaVet, Inc., Bayer AG, BoehringerIngelheim, Ceva Sante Animale S.A., Covetrus, Inc., Elanco, IDEXX Laboratories, Inc., Karyopharm Therapeutics, Inc.,, Morphogenesis, Inc., Nippon Zenyaku Kogyo Co., Ltd., One Health, One Health, PetCure Oncology, PetCure Oncology, LLC, PharmAust, Regeneus Ltd., Rhizen Pharmaceutical SA, Varian Medical Systems, VetDC Inc, Veterinary Cancer Group, Vetoquinol SA, Virbac SA, and Zoetis Karyopharm Therapeutics, Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Veterinary Oncology Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Veterinary Oncology Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Veterinary Oncology Market?
4. What is the competitive strategic window for opportunities in the Global Veterinary Oncology Market?
5. What are the technology trends and regulatory frameworks in the Global Veterinary Oncology Market?
6. What is the market share of the leading vendors in the Global Veterinary Oncology Market?
7. What modes and strategic moves are considered suitable for entering the Global Veterinary Oncology Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AB Science SA
  • Bayer AG
  • Covetrus, Inc.
  • Morphogenesis, Inc.
  • PetCure Oncology
  • Regeneus Ltd.
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Therapy Outlook
3.4. Cancer Type Outlook
3.5. Animal Type Outlook
3.6. Geography Outlook
3.7. Competitor Outlook

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of cancer in pet animals
5.1.1.2. Growing R&D initiatives for cancer management
5.1.1.3. Technological advancement in pet treatment
5.1.2. Restraints
5.1.2.1. High cost of pet cancer treatment
5.1.3. Opportunities
5.1.3.1. Rising awareness regarding veterinary cancer therapies
5.1.3.2. Favorable government initiatives
5.1.4. Challenges
5.1.4.1. Adverse effect of drugs used for pet cancer treatment
5.2. Cumulative Impact of COVID-19
5.3. Porters Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry

6. Veterinary Oncology Market, by Therapy
6.1. Introduction
6.2. Chemotherapy
6.3. Immunotherapy
6.4. Radiology
6.5. Surgery

7. Veterinary Oncology Market, by Animal Type
7.1. Introduction
7.2. Canine
7.3. Feline

8. Veterinary Oncology Market, by Cancer Type
8.1. Introduction
8.2. Lymphoma
8.3. Mammary and Squamous Cell Cancer
8.4. Mast Cell Cancer

9. Americas Veterinary Oncology Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
9.6.1. California
9.6.2. Florida
9.6.3. Illinois
9.6.4. New York
9.6.5. Ohio
9.6.6. Pennsylvania
9.6.7. Texas

10. Asia-Pacific Veterinary Oncology Market
10.1. Introduction
10.2. China
10.3. India
10.4. Indonesia
10.5. Japan
10.6. Malaysia
10.7. Philippines
10.8. South Korea
10.9. Thailand

11. Europe, Middle East & Africa Veterinary Oncology Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. AB Science SA
13.2. Accuray Incorporated
13.3. AdvaVet, Inc.
13.4. Bayer AG
13.5. BoehringerIngelheim
13.6. Ceva Sante Animale S.A.
13.7. Covetrus, Inc.
13.8. Elanco
13.9. IDEXX Laboratories, Inc.
13.10. Karyopharm Therapeutics, Inc.,
13.11. Morphogenesis, Inc.
13.12. Nippon Zenyaku Kogyo Co., Ltd.
13.13. One Health
13.14. One Health
13.15. PetCure Oncology
13.16. PetCure Oncology, LLC
13.17. PharmAust
13.18. Regeneus Ltd.
13.19. Rhizen Pharmaceutical SA
13.20. Varian Medical Systems
13.21. VetDC Inc
13.22. Veterinary Cancer Group
13.23. Vetoquinol SA
13.24. Virbac SA
13.25. Zoetis Karyopharm Therapeutics, Inc.

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
14.3. Contact Details

List of Tables
TABLE 1. GLOBAL VETERINARY ONCOLOGY MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CHEMOTHERAPY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY IMMUNOTHERAPY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY RADIOLOGY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY SURGERY, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANINE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY FELINE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY LYMPHOMA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAMMARY AND SQUAMOUS CELL CANCER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL VETERINARY ONCOLOGY MARKET SIZE, BY MAST CELL CANCER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AMERICAS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. ARGENTINA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. BRAZIL VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. CANADA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. MEXICO VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. UNITED STATES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CALIFORNIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. CALIFORNIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. CALIFORNIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. FLORIDA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. FLORIDA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. FLORIDA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. ILLINOIS VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. ILLINOIS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. ILLINOIS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. NEW YORK VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. NEW YORK VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. NEW YORK VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. OHIO VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. OHIO VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. OHIO VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. PENNSYLVANIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. PENNSYLVANIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. PENNSYLVANIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. TEXAS VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. TEXAS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. TEXAS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. ASIA-PACIFIC VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. CHINA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. INDIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. INDONESIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. JAPAN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. MALAYSIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. PHILIPPINES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. SOUTH KOREA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. THAILAND VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. FRANCE VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. GERMANY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. ITALY VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. NETHERLANDS VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. QATAR VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. RUSSIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. SAUDI ARABIA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. SOUTH AFRICA VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 112. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 113. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 114. SPAIN VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 115. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 116. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 117. UNITED ARAB EMIRATES VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 118. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY THERAPY , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 119. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 120. UNITED KINGDOM VETERINARY ONCOLOGY MARKET SIZE, BY ANIMAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 121. GLOBAL VETERINARY ONCOLOGY MARKET: SCORES
TABLE 122. GLOBAL VETERINARY ONCOLOGY MARKET: BUSINESS STRATEGY
TABLE 123. GLOBAL VETERINARY ONCOLOGY MARKET: PRODUCT SATISFACTION
TABLE 124. GLOBAL VETERINARY ONCOLOGY MARKET: RANKING
TABLE 125. GLOBAL VETERINARY ONCOLOGY MARKET: MERGER & ACQUISITION
TABLE 126. GLOBAL VETERINARY ONCOLOGY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 127. GLOBAL VETERINARY ONCOLOGY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 128. GLOBAL VETERINARY ONCOLOGY MARKET: INVESTMENT & FUNDING
TABLE 129. GLOBAL VETERINARY ONCOLOGY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 130. GLOBAL VETERINARY ONCOLOGY MARKET: LICENSE & PRICING
TABLE 131. GLOBAL VETERINARY ONCOLOGY MARKET: CONTACT DETAILS
Note: Product cover images may vary from those shown
  • AB Science SA
  • Accuray Incorporated
  • AdvaVet, Inc.
  • Bayer AG
  • BoehringerIngelheim
  • Ceva Sante Animale S.A.
  • Covetrus, Inc.
  • Elanco
  • IDEXX Laboratories, Inc.
  • Karyopharm Therapeutics, Inc.,
  • Morphogenesis, Inc.
  • Nippon Zenyaku Kogyo Co., Ltd.
  • One Health
  • One Health
  • PetCure Oncology
  • PetCure Oncology, LLC
  • PharmAust
  • Regeneus Ltd.
  • Rhizen Pharmaceutical SA
  • Varian Medical Systems
  • VetDC Inc
  • Veterinary Cancer Group
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Karyopharm Therapeutics, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll